Hologic Showcased Latest Advances at Virtual ECR Congress 2020
|
By LabMedica International staff writers Posted on 20 Aug 2020 |
|
Illustration
Hologic, Inc. (Marlborough, MA, USA) showcased its latest advances and shared its new innovations on its virtual booth at the online ECR 2020 event held on July 15-21.
ECR 2020 was the first ever online congress to be held by the European Society of Radiology (ESR) due to the COVID-19 pandemic and attracted a record 15,265 professional delegates from over 130 countries. The Virtual Exhibition was attended by 216 companies which demonstrated their products, hosted webinars and invited attendees to visit their very own digital booths. Hologic also used its virtual booth at ECR 2020 to demonstrate how the company’s clinically proven, integrated solutions incorporating artificial intelligence (AI) can support management of patients across the breast health continuum of care.
At ECR 2020, Hologic demonstrated its Unifi Workspace solution which integrates reading of MRI, ultrasound and mammography into one dedicated platform, and is designed to allow for more efficient review of breast images. The company also showcased its 3DQuorum Imaging Technology, Powered by Genius AI, which significantly reduces mammography exam reading times without compromising image quality, sensitivity or accuracy.
Also on display at Hologic’s virtual booth at ECR 2020 was the company’s Faxitron Path+ Specimen Radiography System which enables pathologists to image a wide range of specimens of varying sizes and have immediate access to high-definition X-ray images, directly in the pathology lab. Hologic also demonstrated its Faxitron Trident HD Specimen Radiography System which delivers enhanced image quality, improved workflow and instant sample verification during breast-conserving surgeries and stereotactic breast biopsies.
Among other innovations showcased at ECR 2020 by Hologic was the LOCalizer Wireless Radio Frequency Identification (RFID) Breast Lesion Localization System, a non-radioactive, radiofrequency localization system designed for precise marking and targeting of lesions in breast-conserving surgery. Attendees to Hologic’s virtual booth at ECR 2020 also got a glimpse of the company’s new Aixplorer Mach 30 Breast Ultrasound System which provides fast, high quality imaging and is the first to offer an intuitive touchpad control and large adjustable touchscreen display.
Related Links:
Hologic, Inc.
.jpg)
ECR 2020 was the first ever online congress to be held by the European Society of Radiology (ESR) due to the COVID-19 pandemic and attracted a record 15,265 professional delegates from over 130 countries. The Virtual Exhibition was attended by 216 companies which demonstrated their products, hosted webinars and invited attendees to visit their very own digital booths. Hologic also used its virtual booth at ECR 2020 to demonstrate how the company’s clinically proven, integrated solutions incorporating artificial intelligence (AI) can support management of patients across the breast health continuum of care.
At ECR 2020, Hologic demonstrated its Unifi Workspace solution which integrates reading of MRI, ultrasound and mammography into one dedicated platform, and is designed to allow for more efficient review of breast images. The company also showcased its 3DQuorum Imaging Technology, Powered by Genius AI, which significantly reduces mammography exam reading times without compromising image quality, sensitivity or accuracy.
Also on display at Hologic’s virtual booth at ECR 2020 was the company’s Faxitron Path+ Specimen Radiography System which enables pathologists to image a wide range of specimens of varying sizes and have immediate access to high-definition X-ray images, directly in the pathology lab. Hologic also demonstrated its Faxitron Trident HD Specimen Radiography System which delivers enhanced image quality, improved workflow and instant sample verification during breast-conserving surgeries and stereotactic breast biopsies.
Among other innovations showcased at ECR 2020 by Hologic was the LOCalizer Wireless Radio Frequency Identification (RFID) Breast Lesion Localization System, a non-radioactive, radiofrequency localization system designed for precise marking and targeting of lesions in breast-conserving surgery. Attendees to Hologic’s virtual booth at ECR 2020 also got a glimpse of the company’s new Aixplorer Mach 30 Breast Ultrasound System which provides fast, high quality imaging and is the first to offer an intuitive touchpad control and large adjustable touchscreen display.
Related Links:
Hologic, Inc.
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Slide Scanner System
NanoZoomer S540MD
Gold Member
Platelet Function Analyzer
PL-12
Latest Business News
Channels
Clinical Chemistry
view channel
Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome
Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more
Study Questions Broad Fasting Requirements Before Routine Blood Tests
Routine blood testing is central to diagnosis, monitoring, and disease risk assessment. Many patients are still asked to fast for 8–12 hours before phlebotomy, even though the requirement was originally... Read more
Elevated Lipoprotein(a) Linked to Long-Term Progression of Carotid Atherosclerosis
Lipoprotein(a), or Lp(a), is a genetically determined blood lipid and an important risk factor for cardiovascular disease. Its relationship to long-term carotid atherosclerosis has remained unclear, particularly... Read more
Molecular Diagnostics
view channel
Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants
Inherited cancer risk can influence diagnosis, treatment planning, and family screening, yet current testing practices often depend on a patient’s age at diagnosis. Many patients undergo germline genetic... Read more
New NGS Suite Expands Clonality and MRD Research in Lymphoid Malignancies
Lymphoid malignancies require molecular tools that can distinguish clonal immune receptor rearrangements and track disease-related sequences over time. As immune receptor measurable residual disease analysis... Read more
Tumor-Informed ctDNA Test Shows Utility Across Gastrointestinal and Gynecologic Cancers
Natera announced new data on Signatera, its tumor-informed circulating tumor DNA test, that were presented in four oral presentations at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.... Read more
Hematology
view channel
New Donor Genetic Marker May Help Predict Stem Cell Transplant Success
Donor selection for hematopoietic stem cell transplantation plays a major role in relapse risk and survival for patients with blood cancers and other blood disorders. Despite advances in genotyping, uncertainty... Read more
Updated Ferritin Thresholds Improve Detection of Iron Deficiency
Iron deficiency is one of the most common health conditions worldwide, yet its nonspecific symptoms can delay diagnosis for months. Variation in testing practices and ferritin thresholds may contribute... Read more
Immunology
view channel
Single-Tier Lyme Disease Test Shows High Sensitivity in Early Infection
Lyme disease can be difficult to diagnose during the earliest stages of infection, when conventional serologic testing may have limited sensitivity. Patients may present during a diagnostic gray zone in... Read more
New Web-Based Platform Helps Autoimmune Laboratories Manage Testing Complexity
Autoimmune disease testing often requires laboratories to coordinate results across multiple instruments, manual microscopy, and patient histories. As testing volumes and workflow complexity increase,... Read more
Microbiology
view channel
Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis
Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more
Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification
Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more
Genomic Workflow Identifies Fungal Pathogens Before Blood Cultures Turn Positive
Fungal bloodstream infections pose a major threat to hospitalized patients. Candida species cause most invasive fungal infections worldwide and are among the leading causes of hospital-acquired bloodstream... Read more
FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample
Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read morePathology
view channel
Rapid Mass Spectrometry Test May Aid Glioma Margin Decisions
Glioma brain tumors are highly infiltrative and can extend into nearby healthy brain tissue, making tumor margins difficult to define during surgery. Residual tumor cells may contribute to recurrence and... Read more
Genomic Classifier Predicts Benefit From Adding Hormone Therapy to Salvage Prostate Radiation
Men who have undergone prostatectomy for prostate cancer may later develop a detectable or rising prostate-specific antigen, prompting salvage radiation therapy. A key challenge is determining who is most... Read more
Technology
view channel
Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns
Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more
Laser-Enhanced Assay Boosts Sensitivity for Colorectal Cancer Biomarker Detection
Colorectal cancer is the third most commonly diagnosed cancer and the second leading cause of cancer-related death worldwide. Early detection remains critical, but cancer biomarkers can produce only faint... Read more
Industry
view channel
Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China
Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Collaboration Advances Automated Benchtop Platform for Routine Blood Testing
Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Expanded Partnership Supports AI Biomarker Validation and Clinical Trial Deployment
CellCarta (Montreal, Canada) and Imagene AI (Miami, FL, USA) have expanded their collaboration to provide biopharma companies with a coordinated pathway for biomarker strategy, assay development, validation,... Read more